SHARE THIS ARTICLE:

Columbia University/LDA – 18th Annual Lyme CME Conference

DrFallonSm 640x794The Lyme Disease Association announces its 18th annual Lyme & Other Tick-Borne Diseases scientific conference will be held September 23 & 24, 2017. It is being held in Philadelphia, PA at the Hilton Penns Landing on the banks of the Delaware. Columbia University jointly provides the conference.  CONFERENCE FULL AND CLOSED

Lyme & Other Tick-Borne Diseases Conference:
What Clinicians Need to Know about an Expanding Epidemic

Hilton Penns Landing, Philadelphia, PA

September 23-24, 2017

 

hilton penns landing 900vp

 

Jointly provided by

Columbia University College of P & S

and

Lyme Disease Association, Inc.

 

 


Registration

This conference is designed for medical & health professionals & researchers. The conference is also open for the general public to register. Adults only.

CONFERENCE FULL AND CLOSED

► Registration Fees: 

  • Continuing Medical Education (CME) Registration  $440 (9-22-17 thru 9-24-17@ door)*
  • Non CME (Regular Registration) Registration           $270 (9-22-17 thru 9-24-17@ door)*
  • Continuing Nursing Education (CNE) Registration    $375 (9-22-17 thru 9-24-17@ door)*

This continuing nursing education activity was approved by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity has been approved for 13.76 CNE hours.

For more information regarding contact hours, please contact Lee-Ann Gordon RN, MSN/PHN at [email protected]

(All times and dates are calculated based on Eastern time zone.)

►At the event on Saturday & Sunday, there is a CASH or CHECK ONLY policy when registering “at the door,” if there is space. There is no one day registration category, full registration fee must be paid.

► No phone or fax registrations accepted

► CANCELLATION:

Registration is NON-REFUNDABLE if cancelled after 11:59pm 8-5-17.  Written notice of cancellation must be received by LDA by that time for refund.  NO EXCEPTIONS.  

If written cancellation is received before 11:59PM  8-5-17, 80% of the registration price will be refunded.

Email cancellation notice to [email protected] or fax 732-938-7215. Deadlines are based on Eastern Time and time of receipt.

► AVAILABILITY: Registration subject to space availability at the time of receipt by LDA of completed registration. NO registrations accepted without payment at time of receipt.
At the door registration is limited by space (check website day of conference to see if available, if so you must bring a check/cash to door).

NOTE:The LDA reserves the right to dismiss any registrant without cause at its discretion.

Questions on registration contact: [email protected]


Scholarships – NO MORE SCHOLARSHIPS AVAILABLE

The Lyme Disease Association, Inc. (LDA) is offering scholarships to the conference to eligible medical students, residents, post-doctoral candidates, fellows, veterinarians with equivalent status to the above, and nurse practitioner candidates.
More Info & Scholarship Application


Exhibitors

A limited number of exhibitor space is available for the conference on a “first come” basis. Payment in full at time of registration is required. No refunds.

More Info & Exhibitor Registration


Poster Presentation Information

Conference poster submissions: please email the copy to [email protected] by July 1, 2017 for review and determination of acceptance. All decisions by the review committee are final. Poster presenters must be registered conference attendees.


Accreditation, Disclosure, Audience & Learning Objectives

Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the College of Physicians and Surgeons of Columbia University and the Lyme Disease Association. The College of Physicians and Surgeons of Columbia University is accredited by the ACCME to provide continuing medical education for physicians. AMA Credit Designation Statement: The College of Physicians and Surgeons designates this live activity for a maximum 14.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Disclosure: The College of Physicians and Surgeons must ensure balance, independence, objectivity, and scientific rigor in its educational activities.

Disclosure: All faculty participating in this activity are required to disclose to the audience any significant financial interest and/or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in his/her presentation and/or the commercial contributor(s) of this activity. When unlabeled uses are discussed, these will also be indicated.

Target Audience: The target population is physicians from all specialties, nurses, psychologists, scientists, public health, other health related professionals. It is open to the public & Lyme disease educators usually attend. Geographic area is nationwide, no special background required, although those whose practices contain high proportion of Lyme patients and those whose research concentrate on Borrelia burgdorferi will receive most benefit.

Learning Objectives: Practitioner should be better able to describe the role of inflammation and autoimmunity in persistent symptoms related to Lyme disease. Practitioner should be better informed about new diagnostic advances. Practitioner should become more knowledgeable about antibiotic treatments for patients with neurologic Lyme disease. Awareness that there are a wide array of new strategies to prevent tick-borne infections. Awareness of how Lyme disease infection can affect cardiac function.


2017 Scientific Conference Jointly Provided by

LDA Columbia Logob    


THANK YOU!
The LDA received educational gift support for this conference from the
Steven & Alexandra Cohen Foundation CohenLogo The LDA received commercial support from
IGeneX, Inc.